Natchus M G, Cheng M, Wahl C T, Pikul S, Almstead N G, Bradley R S, Taiwo Y O, Mieling G E, Dunaway C M, Snider C E, McIver J M, Barnett B L, McPhail S J, Anastasio M B, De B
Procter and Gamble Pharmaceuticals, Health Care Research Center, Mason, OH 45040, USA.
Bioorg Med Chem Lett. 1998 Aug 18;8(16):2077-80. doi: 10.1016/s0960-894x(98)00370-9.
A novel series of conformationally constrained matrix metalloprotease inhibitors was identified. The potencies observed for these inhibitors were highly dependent upon the substitution pattern on the caprolactam ring as well as the succinate moiety.